BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Apecotrep readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Apecotrep\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07355296-902@assetmemo.bio
DTSTAMP:20261121T004422Z
DTSTART;VALUE=DATE:20280120
DTEND;VALUE=DATE:20280121
SUMMARY:Apecotrep: Phase 2 readout est. (NCT07355296)
DESCRIPTION:Apecotrep\, phase 2\, Chronic Kidney Disease.\nStudy: PODOMOUNT
 -Basket\, a Study to Test Whether BI 764198 Helps Adults and Adolescents W
 ith Different Types of Kidney Disease\nEstimated primary completion: 20 Ja
 nuary 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readou
 t date\, and it can move.\nDrug page: https://assetmemo.bio/drug/apecotrep
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT073
 55296
URL:https://assetmemo.bio/drug/apecotrep#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07220083-902@assetmemo.bio
DTSTAMP:20261121T004422Z
DTSTART;VALUE=DATE:20281227
DTEND;VALUE=DATE:20281228
SUMMARY:Apecotrep: Phase 3 readout est. (NCT07220083)
DESCRIPTION:Apecotrep\, phase 3\, Chronic Kidney Disease.\nStudy: A Study t
 o Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Conditi
 on Called Focal Segmental Glomerulosclerosis (FSGS)\nEstimated primary com
 pletion: 27 December 2028. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/apecotrep#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT07220083
URL:https://assetmemo.bio/drug/apecotrep#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
